Relmada Therapeutics (RLMD) Return on Capital Employed Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4,853.00 |
| 10 | Relmada Therapeutics | 595.35 Mn | 595.35 Mn | - | 7,289.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,289.00 |
| Dec 31, 2025 | -2,075.00 |
| Sep 30, 2025 | -36,491.00 |
| Jun 30, 2025 | -28,653.00 |
| Mar 31, 2025 | -18,334.00 |
| Dec 31, 2024 | -11,876.00 |
| Sep 30, 2024 | -2,963.00 |
| Jun 30, 2024 | -4,083.00 |
| Mar 31, 2024 | -5,080.00 |
| Dec 31, 2023 | -5,810.00 |
| Sep 30, 2023 | -6,981.00 |
| Jun 30, 2023 | -8,315.00 |
| Mar 31, 2023 | -8,977.00 |
| Dec 31, 2022 | -7,169.00 |
| Jun 30, 2022 | 25,490.00 |
| Mar 31, 2022 | 128,868.00 |
| Dec 31, 2021 | 166,858.00 |
| Sep 30, 2021 | -29,022.00 |
| Mar 31, 2021 | 446,087.00 |
| Dec 31, 2020 | 37,252.00 |
| Sep 30, 2020 | 83,365.00 |
| Jun 30, 2020 | 31,109.00 |
| Mar 31, 2020 | 19,225.00 |
| Dec 31, 2019 | 12,838.00 |
| Jun 30, 2019 | -14,207.00 |
| Mar 31, 2019 | -121,358.00 |
| Dec 31, 2018 | -161,655.00 |
| Sep 30, 2018 | 26,807.00 |
| Mar 31, 2018 | -402,933.00 |
| Dec 31, 2017 | 55,208.00 |
| Sep 30, 2017 | -95,198.00 |